Amgen Foundation and Changemakers Launch Global Online Competition to Empower Patients

Amgen Inc.The Amgen Foundation is supporting an online competition with Ashoka's Changemakers to find the best solutions that elevate patients' voices to improve health outcomes globally.

The Patients | Choices | Empowerment competition is seeking solutions that tap the medical experience, knowledge, and wisdom of current and past patients, health care practitioners, advocates and other key stakeholders to ensure that patients have an active role in their personal healthcare. The ideal solutions are those that empower the patient and provide avenues for informed decisions.

"With healthcare a key concern around the globe, the Amgen Foundation hopes the competition will surface solutions that can give patients the knowledge and confidence to participate collaboratively at every stage of their healthcare," said Jean J. Lim, president of the Amgen Foundation.

The competition takes place at www.changemakers.com/empower-patient where visitors can enter the competition, discuss and share ideas related to patient empowerment, comment on entries, and vote for the finalists. Finalists will be selected by an expert panel of judges based on innovation, social impact, and sustainability. Three winners will each be awarded US$10,000. Entries will be accepted until Sept. 29, 2010 and the winners will be announced in December 2010.

"We look forward to seeing the global Changemakers community, including Ashoka's network of social entrepreneurs, collaborate to build a worldwide network of support for patients so they experience better health outcomes," said Sushmita Ghosh, founder and chair of Ashoka's Changemakers. "This competition will encourage participants to innovate and collaborate, form partnerships, and build a movement that empowers patients."

Following the Changemakers competition, selected entries may be invited to submit proposals to the Amgen Foundation for future funding consideration. The Amgen Foundation will consider awarding up to US$1 million in grants to support promising innovations in patient empowerment submitted by qualifying nonprofit organizations.

About Ashoka's Changemakers
Ashoka's Changemakers is a community of action that connects social entrepreneurs around the globe to share ideas, inspire, and mentor each other. Through its online collaborative competitions and open-source process, Changemakers.com is one of the world's most robust spaces for launching, discussing, and funding ideas to solve the world's most pressing social problems. Changemakers builds on Ashoka's three decade history and belief that we all have the ability to be a Changemaker.
www.Changemakers.com

About The Amgen Foundation
The Amgen Foundation (http://www.amgen.com/citizenship/overview.html) seeks to advance science education; improve patient access to quality care; and strengthen the communities where Amgen staff members live and work. Since 1991, the Foundation has made more than $140 million in grants to nonprofit organizations throughout the United States, Puerto Rico, and Europe that impact society in inspiring and innovative ways, and those that provide disaster relief efforts both domestically and internationally.

Most Popular Now

Novartis signs initial agreement to reserve capaci…

Novartis has signed an initial agreement with Roche to reserve capacity and implement the technology transfer for the production of the active pharmaceutical ingredient (...

Pfizer acquires Amplyx Pharmaceuticals

Pfizer Inc. (NYSE: PFE) announced today that it has acquired Amplyx Pharmaceuticals, Inc., a privately-held company dedicated to the development of therapies for debilita...

Moderna announces additional investments to increa…

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, today announced it is making new funding commitments to i...

Moderna announces emergency use listing granted by…

Moderna, Inc. (Nasdaq: MRNA), a biotechnology company pioneering messenger RNA (mRNA) therapeutics and vaccines, announced that the World Health Organization (WHO) has is...

Sanofi to help manufacture Moderna COVID-19 vaccin…

Sanofi has entered into an agreement with Moderna, under which Sanofi will help manufacture Moderna's COVID-19 vaccine, supporting the COVID-19 pandemic and vaccine suppl...

Valneva switches focus to bilateral discussions to…

Valneva SE, a specialty vaccine company focused on the development and commercialization of prophylactic vaccines for infectious diseases with significant unmet medical n...

Speeding new treatments

A year into the COVID-19 pandemic, mass vaccinations have begun to raise the tantalizing prospect of herd immunity that eventually curtails or halts the spread of SARS-Co...

Pfizer and BioNTech to supply the European Union w…

Pfizer Inc. (NYSE: PFE) and BioNTech SE (Nasdaq: BNTX) announced they will supply an additional 100 million doses of COMIRNATY®, the companies' COVID-19 vaccine, to the 2...

Brazilian coronavirus variant likely to be more tr…

Even though more and more vaccines against the coronavirus are being administered all over the world, many countries are still battling with outbreaks and face difficulti...

Patients who are obese or overweight are at risk f…

COVID-19 patients who are overweight or obese are more likely to develop a more severe infection than patients of healthy weight, and they require oxygen and invasive mec...

Updated results on coronavirus vaccination effecti…

Several weeks following the publication of the large real-world COVID-19 vaccine effectiveness study by the Clalit Research Institute in Collaboration with Harvard Univer...

Our immune systems blanket the SARS-CoV-2 spike pr…

The most complete picture yet is coming into focus of how antibodies produced in people who effectively fight off SARS-CoV-2 work to neutralize the part of the virus resp...